Cancer
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://cancerfund.com
- HQ
- AZ
Cancer is an early-stage oncology investor focused on pre-seed and seed companies. It works with a community of physicians, researchers, and survivors who help source and evaluate investments.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Seed, Series A | Not enough dated deals |
| Sectors | Biotech | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| CANCER FUND I, LLC | 2023 | $383K to $10M (Form D) | Open, writing first checks |
03 · People across funds
- Anthony Bajoras
CANCER FUND I, LLC (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- https://cancerfund.com
- https://cancerfund.com/contact-us/
- https://cancerfund.com/
- https://cancerfund.com/why-cancer-fund/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026